Ephrin B2 and EphB4 selectively mark arterial and venous vessels in cerebral arteriovenous malformation

Journal of International Medical Research

Volumn 42, Issue 2, 2014, Pages 405-415

  Bai, Jie ^a   Wang, Ya jie ^a   Liu, Li ^a   Zhao, Yuan li ^a  

^a CAPITAL MEDICAL UNIVERSITY   (China)

Author keywords

arteriovenous plasticity; Cerebral arteriovenous malformation; EphB4; ephrin B2

Indexed keywords

ARTERIOVENOUS PLASTICITY; CEREBRAL ARTERIOVENOUS MALFORMATION; EPHB4; EPHRIN B2;

ADOLESCENT; ADULT; CHILD; ENDOTHELIAL CELLS; ENDOTHELIUM, VASCULAR; EPHRIN-B2; FEMALE; HUMANS; INTRACRANIAL ARTERIOVENOUS MALFORMATIONS; MALE; MIDDLE AGED; MUSCLE, SMOOTH, VASCULAR; NEOVASCULARIZATION, PATHOLOGIC; PROTEIN BINDING; RECEPTOR, EPHB4; RECEPTORS, VASCULAR ENDOTHELIAL GROWTH FACTOR; RETROSPECTIVE STUDIES; VASCULAR ENDOTHELIAL GROWTH FACTOR A; YOUNG ADULT;

EID: 84898686930     PISSN: 03000605     EISSN: 14732300     Source Type: Journal    
DOI: 10.1177/0300060513478091     Document Type: Article

References (43)

1. Lamorte L,Park M.The receptor tyrosine kinases: role in cancer progression.Surg Oncol Clin N Am. 2001;10:271-288.
2. Dodelet VC,Pasquale EB.Eph receptors and ephrin ligands: embryogenesis to tumorigenesis.Oncogene. 2000;19:5614-5619.
3. Nakamoto M,Bergemann AD.Diverse roles for the Eph family of receptor tyrosine kinases in carcinogenesis.Microsc Res Tech. 2002;59:58-67.
4. Sakano S,Serizawa R,Inada T, et al.Characterization of a ligand for receptor protein-tyrosine kinase HTK expressed in immature hematopoietic cells.Oncogene. 1996;13:813-822.
5. Pasquale EB.Eph-ephrin bidirectional signaling in physiology and disease.Cell. 2008;133:38-52.
6. Füller T,Korff T,Kilian A, et al.Forward EphB4 signaling in endothelial cells controls cellular repulsion and segregation from ephrin B2 positive cells.J Cell Sci. 2003;116:2461-2470.
7. Hamada K,Oike Y,Ito Y, et al.Distinct roles of ephrin-B2 forward and EphB4 reverse signaling in endothelial cells.Arterioscler Thromb Vasc Biol. 2003;23:190-197.
8. Wang HU,Chen ZF,Anderson DJ.Molecular distinction and angiogenic interaction between embryonic arteries and veins revealed by ephrin-B2 and its receptor Eph-B4.Cell. 1998;93:741-753.
9. Alkadhi H,Kollias SS,Crelier GR, et al.Plasticity of the human motor cortex in patients with arteriovenous malformations: a functional MR imaging study.AJNR Am J Neuroradiol. 2000;21:1423-1433.
10. Fleetwood IG,Steinberg GK.Arteriovenous malformations.Lancet. 2002;359:863-873.
11. Abdulrauf SI,Malik GM,Awad IA.Spontaneous angiographic obliteration of cerebral arteriovenous malformations.Neurosurgery. 1999;44:280-287.
12. Hatva E,Jääskeläinen J,Hirvonen H, et al.Tie endothelial cell-specific receptor tyrosine kinase is upregulated in the vasculature of arteriovenous malformations.J Neuropathol Exp Neurol. 1996;55:1124-1133.
13. Lawton MT,Jacobowitz R,Spetzler RF.Redefined role of angiogenesis in the pathogenesis of dural arteriovenous malformations.J Neurosurg. 1997;87:267-274.
14. Easty DJ,Hill SP,Hsu MY, et al.Up-regulation of ephrin-A1 during melanoma progression.Int J Cancer. 1999;84:494-501.
15. Walker-Daniels J,Coffman K,Azimi M, et al.Overexpression of the EphA2 tyrosine kinase in prostate cancer.Prostate. 1999;41:275-280.
16. Miyazaki T,Kato H,Fukuchi M, et al.EphA2 overexpression correlates with poor prognosis in esophageal squamous cell carcinoma.Int J Cancer. 2003;103:657-663.
17. Hashimoto T,Emala CW,Joshi S, et al.Abnormal pattern of Tie-2 and vascular endothelial growth factor receptor expression in human cerebral arteriovenous malformations.Neurosurgery. 2000;47:910-918.
18. VEGF-C signaling pathways through VEGFR-2 and VEGFR-3 in vasculoangiogenesis and hematopoiesis.Blood. 2000;96:3793-3800.
19. Gault J,Sarin H,Awadallah NA, et al.Pathobiology of human cerebrovascular malformations: basic mechanisms and clinical relevance.Neurosurgery. 2004;55:1-16.
20. Shenkar R,Elliott JP,Diener K, et al.Differential gene expression in human cerebrovascular malformations.Neurosurgery. 2003;52:465-477.
21. Pellettieri L,Svendsen P,Wikholm G, et al.Hidden compartments in AVMs-a new concept.Acta Radiol. 1997;38:2-7.
22. Oike Y,Ito Y,Hamada K, et al.Regulation of vasculogenesis and angiogenesis by EphB/ephrin-B2 signaling between endothelial cells and surrounding mesenchymal cells.Blood. 2002;100:1326-1333.
23. Gale NW,Baluk P,Pan L, et al.Ephrin-B2 selectively marks arterial vessels and neovascularization sites in the adult, with expression in both endothelial and smooth-muscle cells.Dev Biol. 2001;230:151-160.
24. Taylor AC,Murfee WL,Peirce SM.EphB4 expression along adult rat microvascular networks: EphB4 is more than a venous specific marker.Microcirculation. 2007;14:253-267.
25. Sawamiphak S,Seidel S,Essmann CL, et al.Ephrin-B2 regulates VEGFR2 function in developmental and tumour angiogenesis.Nature. 2010;465:487-491.
26. Kuijper S,Turner CJ,Adams RH.Regulation of angiogenesis by Eph-ephrin interactions.Trends Cardiovasc Med. 2007;17:145-151.
27. Hayashi S,Asahara T,Masuda H, et al.Functional ephrin-B2 expression for promotive interaction between arterial and venous vessels in postnatal neovascularization.Circulation. 2005;111:2210-2218.
28. Gale NW,Baluk P,Pan L, et al.Ephrin-B2 selectively marks arterial vessels and neovascularization sites in the adult, with expression in both endothelial and smooth-muscle cells.Dev Biol. 2001;230:151-160.
29. Adams RH.Molecular control of arterial-venous blood vessel identity.J Anat. 2003;202:105-112.
30. Korff T,Dandekar G,Pfaff D, et al.Endothelial ephrin B2 is controlled by microenvironmental determinants and associates context-dependently with CD31.Arterioscler Thromb Vasc Biol. 2006;26:468-474.
31. Vihanto MM,Plock J,Erni D, et al.Hypoxia up-regulates expression of Eph receptors and ephrins in mouse skin.FASEB J. 2005;19:1689-1691.
32. Lawson ND,Vogel AM,Weinstein BM.Sonic hedgehog and vascular endothelial growth factor act upstream of the Notch pathway during arterial endothelial differentiation.Dev Cell. 2002;3:127-136.
33. Weinstein BM,Lawson ND.Arteries, veins, Notch, and VEGF.Cold Spring Harb Symp Quant Biol. 2002;67:155-162.
34. Lamont RE,Childs S.MAPping out arteries and veins.Sci STKE. 2006;2006:e39-e39.
35. dela Paz NG,D'Amore PA.Arterial versus venous endothelial cells.Cell Tissue Res. 2009;335:5-16.
36. Aitsebaomo J,Portbury AL,Schisler JC, et al.Brothers and sisters: molecular insights into arterial-venous heterogeneity.Circ Res. 2008;103:929-939.
37. Kim YH,Hu H,Guevara-Gallardo S, et al.Artery and vein size is balanced by Notch and ephrin B2/EphB4 during angiogenesis.Development. 2008;135:3755-3764.
38. Hainaud P,Contrerès JO,Villemain A, et al.The role of the vascular endothelial growth factor-Delta-like 4 ligand/Notch4-ephrin B2 cascade in tumor vessel remodeling and endothelial cell functions.Cancer Res. 2006;66:8501-8510.
39. Kume T.Specification of arterial, venous, and lymphatic endothelial cells during embryonic development.Histol Histopathol. 2010;25:637-646.
40. Nunes SS,Greer KA,Stiening CM, et al.Implanted microvessels progress through distinct neovascularization phenotypes.Microvasc Res. 2010;79:10-20.
41. Chang CC,Nunes SS,Sibole SC, et al.Angiogenesis in a microvascular construct for transplantation depends on the method of chamber circulation.Tissue Eng Part A. 2010;16:795-805.
42. Ng I,Tan WL,Ng PY, et al.Hypoxia inducible factor-1alpha and expression of vascular endothelial growth factor and its receptors in cerebral arteriovenous malformations.J Clin Neurosci. 2005;12:794-799.
43. Sho E,Komatsu M,Sho M, et al.High flow drives vascular endothelial cell proliferation during flow-induced arterial remodeling associated with the expression of vascular endothelial growth factor.Exp Mol Pathol. 2003;75:1-11.